A Pilot Study of a Mobile App to Support HIV Antiretroviral Therapy Adherence Among Men Who Have Sex with Men Who Use Stimulants

Keith J Horvath; Sara Lammert; Richard F Maclehose; Thu Danh; Jason V. Baker; Adam W. Carrico

doi:10.1007/s10461-019-02597-3

A Pilot Study of a Mobile App to Support HIV Antiretroviral Therapy Adherence Among Men Who Have Sex with Men Who Use Stimulants

Keith J Horvath, Sara Lammert, Richard F Maclehose, Thu Danh, Jason V. Baker, Adam W. Carrico

Research output: Contribution to journal › Article › peer-review

23 Scopus citations

Abstract

APP+ is a theoretically-grounded mobile app intervention to improve antiretroviral (ART) adherence among men who have sex with men (MSM) who use stimulants. We assessed the feasibility and acceptability of APP+ in a six-month randomized controlled trial among a national sample of 90 MSM recruited online; secondarily, we examined changes in self-reported ART adherence by study arm. Retention at the final assessment was 82%, and acceptability ratings were comparable to other technology-based interventions. MSM in the APP+ group reported higher self-reported percentage ART adherence in the past 30 days at the four-month timepoint compared to a no-treatment control group (89.0% vs. 77.2%). However, once access to the app was removed after month four, group differences in ART adherence diminished by month six. APP+ may be a potentially promising intervention approach for MSM living with HIV who use stimulants but would require enhancements to optimize acceptability and demonstrate more sustained effects.

Original language	English (US)
Pages (from-to)	3184-3198
Number of pages	15
Journal	AIDS and Behavior
Volume	23
Issue number	11
DOIs	https://doi.org/10.1007/s10461-019-02597-3
State	Published - Nov 1 2019

Bibliographical note

Funding Information:
We would like to thank participants for the time they offered during the conduct of this study. Research reported in this publication was supported by the National Institute on Drug Abuse of the National Institutes of Health under Award Number R34DA033833. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Funding Information:
We would like to thank participants for the time they offered during the conduct of this study. Research reported in this publication was supported by the National Institute on Drug Abuse of the National Institutes of Health under Award Number R34DA033833. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Publisher Copyright:
© 2019, Springer Science+Business Media, LLC, part of Springer Nature.

Copyright:
Copyright 2019 Elsevier B.V., All rights reserved.

Keywords

Drug use
HIV/AIDS
Medication adherence
Mobile app

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1007/s10461-019-02597-3

Find It

Find It at U of M Libraries

Cite this

@article{1a2eababc0b64affa6c078c7edf4bd38,

title = "A Pilot Study of a Mobile App to Support HIV Antiretroviral Therapy Adherence Among Men Who Have Sex with Men Who Use Stimulants",

abstract = "APP+ is a theoretically-grounded mobile app intervention to improve antiretroviral (ART) adherence among men who have sex with men (MSM) who use stimulants. We assessed the feasibility and acceptability of APP+ in a six-month randomized controlled trial among a national sample of 90 MSM recruited online; secondarily, we examined changes in self-reported ART adherence by study arm. Retention at the final assessment was 82%, and acceptability ratings were comparable to other technology-based interventions. MSM in the APP+ group reported higher self-reported percentage ART adherence in the past 30 days at the four-month timepoint compared to a no-treatment control group (89.0% vs. 77.2%). However, once access to the app was removed after month four, group differences in ART adherence diminished by month six. APP+ may be a potentially promising intervention approach for MSM living with HIV who use stimulants but would require enhancements to optimize acceptability and demonstrate more sustained effects.",

keywords = "Drug use, HIV/AIDS, Medication adherence, Mobile app",

author = "Horvath, {Keith J} and Sara Lammert and Maclehose, {Richard F} and Thu Danh and Baker, {Jason V.} and Carrico, {Adam W.}",

note = "Funding Information: We would like to thank participants for the time they offered during the conduct of this study. Research reported in this publication was supported by the National Institute on Drug Abuse of the National Institutes of Health under Award Number R34DA033833. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Funding Information: We would like to thank participants for the time they offered during the conduct of this study. Research reported in this publication was supported by the National Institute on Drug Abuse of the National Institutes of Health under Award Number R34DA033833. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Publisher Copyright: {\textcopyright} 2019, Springer Science+Business Media, LLC, part of Springer Nature. Copyright: Copyright 2019 Elsevier B.V., All rights reserved.",

year = "2019",

month = nov,

day = "1",

doi = "10.1007/s10461-019-02597-3",

language = "English (US)",

volume = "23",

pages = "3184--3198",

journal = "AIDS and Behavior",

issn = "1090-7165",

publisher = "Springer New York",

number = "11",

}

TY - JOUR

T1 - A Pilot Study of a Mobile App to Support HIV Antiretroviral Therapy Adherence Among Men Who Have Sex with Men Who Use Stimulants

AU - Horvath, Keith J

AU - Lammert, Sara

AU - Maclehose, Richard F

AU - Danh, Thu

AU - Baker, Jason V.

AU - Carrico, Adam W.

N1 - Funding Information: We would like to thank participants for the time they offered during the conduct of this study. Research reported in this publication was supported by the National Institute on Drug Abuse of the National Institutes of Health under Award Number R34DA033833. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Funding Information: We would like to thank participants for the time they offered during the conduct of this study. Research reported in this publication was supported by the National Institute on Drug Abuse of the National Institutes of Health under Award Number R34DA033833. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Publisher Copyright: © 2019, Springer Science+Business Media, LLC, part of Springer Nature. Copyright: Copyright 2019 Elsevier B.V., All rights reserved.

PY - 2019/11/1

Y1 - 2019/11/1

N2 - APP+ is a theoretically-grounded mobile app intervention to improve antiretroviral (ART) adherence among men who have sex with men (MSM) who use stimulants. We assessed the feasibility and acceptability of APP+ in a six-month randomized controlled trial among a national sample of 90 MSM recruited online; secondarily, we examined changes in self-reported ART adherence by study arm. Retention at the final assessment was 82%, and acceptability ratings were comparable to other technology-based interventions. MSM in the APP+ group reported higher self-reported percentage ART adherence in the past 30 days at the four-month timepoint compared to a no-treatment control group (89.0% vs. 77.2%). However, once access to the app was removed after month four, group differences in ART adherence diminished by month six. APP+ may be a potentially promising intervention approach for MSM living with HIV who use stimulants but would require enhancements to optimize acceptability and demonstrate more sustained effects.

AB - APP+ is a theoretically-grounded mobile app intervention to improve antiretroviral (ART) adherence among men who have sex with men (MSM) who use stimulants. We assessed the feasibility and acceptability of APP+ in a six-month randomized controlled trial among a national sample of 90 MSM recruited online; secondarily, we examined changes in self-reported ART adherence by study arm. Retention at the final assessment was 82%, and acceptability ratings were comparable to other technology-based interventions. MSM in the APP+ group reported higher self-reported percentage ART adherence in the past 30 days at the four-month timepoint compared to a no-treatment control group (89.0% vs. 77.2%). However, once access to the app was removed after month four, group differences in ART adherence diminished by month six. APP+ may be a potentially promising intervention approach for MSM living with HIV who use stimulants but would require enhancements to optimize acceptability and demonstrate more sustained effects.

KW - Drug use

KW - HIV/AIDS

KW - Medication adherence

KW - Mobile app

UR - http://www.scopus.com/inward/record.url?scp=85068974965&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068974965&partnerID=8YFLogxK

U2 - 10.1007/s10461-019-02597-3

DO - 10.1007/s10461-019-02597-3

M3 - Article

C2 - 31309348

AN - SCOPUS:85068974965

SN - 1090-7165

VL - 23

SP - 3184

EP - 3198

JO - AIDS and Behavior

JF - AIDS and Behavior

IS - 11

ER -

A Pilot Study of a Mobile App to Support HIV Antiretroviral Therapy Adherence Among Men Who Have Sex with Men Who Use Stimulants

Abstract

Bibliographical note

Keywords

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this